Délèze G, Björkhem I, Karlaganis G
J Pediatr Gastroenterol Nutr. 1986 Sep-Oct;5(5):701-10. doi: 10.1097/00005176-198609000-00006.
The Zellweger cerebro-hepato-renal syndrome (CHRS) is a rare hereditary disease in which there is a generalized deficiency of peroxisomal function. Liver peroxisomes are important for the conversion of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid into cholic acid, and, consequently, 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid and metabolites of this bile acid precursor accumulate in serum and bile of patients with CHRS. Little is known about the urinary excretion of bile acids in this disease. Using gas chromatography-mass spectrometry we have analyzed serum bile acids and urinary excretion of bile acids and bile alcohols in two Swiss male CHRS patients. As expected, serum concentrations and urinary excretions of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid and 3 alpha,7 alpha,12 alpha,24-tetrahydroxy-5 beta-cholestanoic acid were elevated, which is probably an obligatory finding in CHRS. In addition, the urinary excretion of 1,3,7,12-tetrahydroxy-5 beta-cholanoic acid (a very polar unusual bile acid) was increased (99-1556 nmol/24 h). In contrast, the excretion of the major urinary bile alcohol, 27-nor-5 beta-cholestane-3 alpha, 7 alpha,12 alpha,24,25-pentol was found to be normal. 3 alpha, 7 alpha,12 alpha-Trihydroxy-5 beta-C29-dicarboxylic acid, a metabolite of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid previously believed to be obligatory in CHRS, was found only in one of our patients.
泽尔韦格脑肝肾综合征(CHRS)是一种罕见的遗传性疾病,其过氧化物酶体功能普遍缺乏。肝脏过氧化物酶体对于将3α,7α,12α-三羟基-5β-胆甾烷酸转化为胆酸很重要,因此,3α,7α,12α-三羟基-5β-胆甾烷酸及其胆汁酸前体的代谢产物会在CHRS患者的血清和胆汁中蓄积。关于该疾病中胆汁酸的尿排泄情况知之甚少。我们使用气相色谱-质谱分析法分析了两名瑞士男性CHRS患者的血清胆汁酸以及胆汁酸和胆汁醇的尿排泄情况。正如预期的那样,3α,7α,12α-三羟基-5β-胆甾烷酸和3α,7α,12α,24-四羟基-5β-胆甾烷酸的血清浓度和尿排泄量升高,这可能是CHRS的必然表现。此外,1,3,7,12-四羟基-5β-胆烷酸(一种极性很强的异常胆汁酸)的尿排泄量增加(99 - 1556 nmol/24小时)。相比之下,主要的尿胆汁醇27-去甲-5β-胆甾烷-3α,7α,12α,24,25-戊醇的排泄量正常。3α,7α,12α-三羟基-5β-C29-二羧酸是3α,7α,12α-三羟基-5β-胆甾烷酸的一种代谢产物,此前认为在CHRS中必然存在,而我们仅在一名患者中发现了它。